ED in Europe: A Rising Tide?
Executive Summary
Worldwide launches of new PDE5 inhibitors to treat erectile dysfunction are certain to expand the global market for these and other ED therapies. But in Europe, Viagra's brand ubiquity, the prohibition of DTC advertising, and disparate national markets present challenges to firms hoping to dethrone the Pfizer juggernaut.